Product Images Fluticasone Propionate And Salmeterol
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 24 images provide visual information about the product associated with Fluticasone Propionate And Salmeterol NDC 50090-3387 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
FP chem structure - fluticasone propionate salmeterol inhalation powde 1
Figure 8 - fluticasone propionate salmeterol inhalation powde 10
Teva Logo - fluticasone propionate salmeterol inhalation powde 11
Teva Logo - fluticasone propionate salmeterol inhalation powde 12
Figurr A - fluticasone propionate salmeterol inhalation powde 13
This text appears to refer to an inhaler with a dose counter, a vent, a mouthpiece, and a yellow cap. Further information or context is not available.*
Figure B - fluticasone propionate salmeterol inhalation powde 14
This is a description of an inhaler that has 60 doses when full and zero doses when empty.*
Figure C - fluticasone propionate salmeterol inhalation powde 15
Figure D - fluticasone propionate salmeterol inhalation powde 16
Breathe out image - fluticasone propionate salmeterol inhalation powde 17
Figure F - fluticasone propionate salmeterol inhalation powde 18
Figure G - fluticasone propionate salmeterol inhalation powde 19
Salmeterol chem structure - fluticasone propionate salmeterol inhalation powde 2
Figure H - fluticasone propionate salmeterol inhalation powde 20
Teva Logo - fluticasone propionate salmeterol inhalation powde 21
Figure 1 - fluticasone propionate salmeterol inhalation powde 3
Figure 2 - fluticasone propionate salmeterol inhalation powde 4
Figure 3 - fluticasone propionate salmeterol inhalation powde 5
Figure 4 - fluticasone propionate salmeterol inhalation powde 6
This text represents a table that includes the names of different medications, their doses, and sample sizes (N) of patients who received them. It also presents the mean change in FEV (forced expiratory volume) in liters measured at different time intervals (baseline, 1 hour, day 1, and 2-11 days) after the medication was taken. There is insufficient information to provide a complete description or information about the purpose of the study.*
Figure 5 - fluticasone propionate salmeterol inhalation powde 7
Figure 6 - fluticasone propionate salmeterol inhalation powde 8
Figure 7 - fluticasone propionate salmeterol inhalation powde 9
This is a table showing the mean change in FEV (forced expiratory volume) in liters for different treatments and placebos. The treatments include FSMDPI 232 meg/14 mcg, FSMDPI 113 mcg/14 meg, MDPI 232 meg, and MDPI 113 meg. The placebo group is also included in the study. The table provides the number of participants for each group and shows the mean changes in FEV over time, with data collected on Day 1 and hourly thereafter.*
lbl500903271
lbl500903272
Label Image - lbl500903387
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.